Sarcopenia risk in nursing home residents using SARC-F: First study findings

被引:1
|
作者
Thompson, Mark Q. [1 ]
Jadczak, Agathe D. [1 ]
Yu, Solomon [1 ,2 ]
Tucker, Graeme R. [1 ]
Visvanathan, Renuka [1 ,2 ]
机构
[1] Univ Adelaide, Natl Hlth & Med Res Council NHMRC, Ctr Res Excellence Frailty & Hlth Ageing, Adelaide, SA, Australia
[2] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Geriatr Training & Res Aged Care G TRAC, Adelaide Med Sch, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
aged; Australia; nursing homes; sarcopenia; survival; LONG-TERM-CARE; MUSCLE MASS; FRAILTY; PREVALENCE; MOBILITY;
D O I
10.1111/ggi.14327
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aim Sarcopenia is a common disorder of loss of muscle mass and function among older adults; however, few studies have examined screening instruments for sarcopenia risk in residential aged care services (RACS). The aims of this study were to measure sarcopenia risk in RACS residents using the SARC-F, describe factors associated with sarcopenia risk and examine the predictive validity of the SARC-F for 12-month mortality. Methods This was a prospective cohort study carried out in South Australian RACS across 12 sites. In total, 541 residents (mean age 87.7 [7.3] years, 72.6% women) were included in the study. Sarcopenia risk was measured using a modified SARC-F (>= 4 point cut point). Results We identified 89.5% (n = 484) of residents at risk of sarcopenia. Significant (P > 0.05) predictors of sarcopenia risk in multivariable analysis included the presence of diabetes (relative risk [RR] = 1.08), classification as most-frail (RR = 1.06) and smaller Nursing Home Life Space Diameter (NHLSD) score (RR = 0.99). Mortality was observed in 20.9% (n = 113) of residents over a 12-month follow-up. Classification as at-risk of sarcopenia was a significant predictor of 12-month mortality; however, it had a poor area under the receiver operator curve (0.56), and a low positive predictive value (23.1%). The best performing cut-point of >= 7 also had poor discriminative ability (under the receiver operator curve = 0.66, positive predictive value = 30.8%). Conclusions Sarcopenia risk is extremely common among RACS residents and its presence is a significant contributor to 12-month mortality. Low discriminative ability for the SARC-F was noted across multiple cut-off scores for predicting mortality at 12 months. Diabetes management and promoting physical activity and nutrition among RACS residents are likely to influence sarcopenia risk positively. Geriatr Gerontol Int center dot center dot; center dot center dot: center dot center dot-center dot center dot Geriatr Gerontol Int 2022; center dot center dot: center dot center dot-center dot center dot.
引用
收藏
页码:206 / 212
页数:7
相关论文
共 50 条
  • [31] SARC-F Score: A Quick Bedside Tool to Screen Sarcopenia in Patients With Cirrhosis
    Singla, Neeraj
    Inavolu, Pradev
    Kumar, Bhashyakarla Ramesh
    Macherla, Ramanna
    Reddy, Duvvur Nageshwar
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (03)
  • [32] Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patients
    Fu, Xiaofen
    Tian, Zhen
    Thapa, Sudip
    Sun, Huihui
    Wen, Su
    Xiong, Huihua
    Yu, Shiying
    CLINICAL NUTRITION, 2020, 39 (11) : 3337 - 3345
  • [33] Validation of the Italian Version of the SARC-F Questionnaire to Assess Sarcopenia in Older Adults
    Perna, Simone
    Gasparri, Clara
    Ferraris, Cinzia
    Barrile, Gaetan Claude
    Cavioni, Alessandro
    Mansueto, Francesca
    Patelli, Zaira
    Peroni, Gabriella
    Tartara, Alice
    Zese, Marco
    Rondanelli, Mariangela
    NUTRIENTS, 2022, 14 (12)
  • [34] Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures
    Gülistan Bahat
    O. Yilmaz
    C. Kiliç
    M. M. Oren
    M. A. Karan
    The journal of nutrition, health & aging, 2018, 22 : 898 - 903
  • [35] French translation and validation of the sarcopenia screening tool SARC-F
    Charlotte Beaudart
    Médéa Locquet
    Stephen Bornheim
    Jean-Yves Reginster
    Olivier Bruyère
    European Geriatric Medicine, 2018, 9 : 29 - 37
  • [36] SARC-F for screening of sarcopenia among older adults with cancer
    Williams, Grant R.
    Al-Obaidi, Mustafa
    Dai, Chen
    Bhatia, Smita
    Giri, Smith
    CANCER, 2021, 127 (09) : 1469 - 1475
  • [37] Prevalence and risk factors of sarcopenia in elderly nursing home residents
    Tasar, P. T.
    Sahin, S.
    Karaman, E.
    Ulusoy, M. G.
    Duman, S.
    Berdeli, A.
    Akcicek, F.
    EUROPEAN GERIATRIC MEDICINE, 2015, 6 (03) : 214 - 219
  • [38] Evaluation of the Hungarian-language SARC-F sarcopenia-screening questionnaire
    Gasparik Andrea Ildiko
    Monica-Beata, Demian
    Pascanu Ionela Maria
    Merlan Iulian
    Hodinka Laszlo
    Vereckei Edit
    ORVOSI HETILAP, 2020, 161 (47) : 2000 - 2005
  • [39] Comparing Mini Sarcopenia Risk Assessment With SARC-F for Screening Sarcopenia in Community-Dwelling Older Adults
    Yang, Ming
    Hu, Xiaoyi
    Xie, Lingling
    Zhang, Luoying
    Zhou, Jie
    Lin, Jing
    Wang, Ying
    Li, Yaqi
    Han, Zengli
    Zhang, Daipei
    Zuo, Yun
    Li, Ying
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (01) : 53 - 57
  • [40] SARC-F as a Screening Tool for Sarcopenia and Possible Sarcopenia Proposed by AWGS 2019 in Hospitalized Older Adults
    Ishida, Y.
    Maeda, K.
    Nonogaki, T.
    Shimizu, A.
    Yamanaka, Y.
    Matsuyama, R.
    Kato, R.
    Ueshima, J.
    Murotani, K.
    Mori, N.
    JOURNAL OF NUTRITION HEALTH & AGING, 2020, 24 (10) : 1053 - 1060